Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	97.23	147.73	130.11	106.13	414.99	1,034
Short-Term Investments	51.03	45.82	38.68	31.83	23.62	19.58
Cash & Short-Term Investments	148.26	193.55	168.79	137.97	438.61	1,054
Cash Growth	-15.87%	14.67%	22.34%	-68.54%	-58.38%	911.13%
Accounts Receivable	4,384	4,210	5,584	6,796	3,943	2,662
Other Receivables	10,062	9,706	9,811	8,109	8,458	8,987
Receivables	14,446	13,916	15,395	14,905	12,401	11,649
Inventory	1,572	1,699	1,614	1,660	1,411	1,278
Prepaid Expenses	0.47	0.11	1.1	26.19	43.84	44.52
Other Current Assets	862.69	1,045	1,897	2,026	1,928	3,722
Total Current Assets	17,030	16,853	19,076	18,755	16,223	17,747
Property, Plant & Equipment	29,435	28,265	26,424	23,009	19,856	16,633
Long-Term Investments	7,825	8,067	7,440	6,343	6,254	2,462
Other Long-Term Assets	-	-	-	-	-	-0
Total Assets	54,289	53,186	52,940	48,107	42,333	36,841
Accounts Payable	5,650	5,097	6,259	7,301	4,231	2,619
Accrued Expenses	291.85	298.44	270.03	265.44	232.48	225.55
Short-Term Debt	522.43	556.18	547.82	563.9	564.32	566
Current Portion of Long-Term Debt	67.35	67.35	490.5	387.47	274.33	201.88
Current Portion of Leases	15.41	13.94	23.91	31.66	36.42	38.35
Current Income Taxes Payable	311.7	304.49	435.26	398.62	262.75	197.86
Other Current Liabilities	1,691	1,429	1,444	488.23	406.06	599.16
Total Current Liabilities	8,549	7,766	9,470	9,437	6,008	4,447
Long-Term Debt	22,685	21,864	20,808	17,601	15,930	12,871
Long-Term Leases	30.12	13.71	26.35	35.27	39.9	46.91
Long-Term Deferred Tax Liabilities	359.4	315.43	157.7	122.25	138.28	142.61
Other Long-Term Liabilities	143.41	143.41	143.41	143.41	143.41	143.41
Total Liabilities	31,767	30,103	30,606	27,338	22,259	17,651
Common Stock	2,340	2,340	2,340	2,340	2,340	2,340
Additional Paid-In Capital	8,017	8,017	8,017	8,017	8,017	8,017
Retained Earnings	7,222	7,499	7,400	6,978	6,401	5,670
Comprehensive Income & Other	3,439	3,683	3,067	1,978	1,905	1,937
Total Common Equity	21,018	21,540	20,824	19,313	18,663	17,964
Minority Interest	1,505	1,543	1,510	1,456	1,412	1,226
Shareholders' Equity	22,523	23,083	22,334	20,769	20,074	19,190
Total Liabilities & Equity	54,289	53,186	52,940	48,107	42,333	36,841
Total Debt	23,320	22,515	21,897	18,619	16,844	13,724
Net Cash (Debt)	-23,159	-22,305	-21,700	-18,446	-16,377	-12,647
Net Cash Per Share	-98.97	-95.32	-92.74	-78.83	-69.99	-54.05
Filing Date Shares Outstanding	234	234	234	234	234	234
Total Common Shares Outstanding	234	234	234	234	234	234
Working Capital	8,481	9,087	9,606	9,318	10,216	13,299
Book Value Per Share	89.82	92.05	88.99	82.53	79.76	76.77
Tangible Book Value	21,018	21,540	20,824	19,313	18,663	17,964
Tangible Book Value Per Share	89.82	92.05	88.99	82.53	79.76	76.77

Source: S&P Capital IQ. Standard template. Financial Sources.